Deleted Tweets From Scott Gottlieb, R-D.C.

RT @SueDHellmann: “Imagine what’s possible if we work together,” Gates said.” Many great examples of how we work with the private sector- i… QT @gatesfoundation: "@gavi and @GlobalFund show people that if you do come up with an innovation, there’s funding to get them out to de… https://t.co/hYZoSVeq1U)

1/3 #FDA expects shortage of IV fluids to improve in coming weeks. We're working with manufacturers to get #PuertoRico facilities to full capacity; also permitting imports of product to US from 3 new manufacturers; looking at add’l import sites for saline

#FDA Workshop: Weighing the Evidence - Variant Classification and Interpretation in Precision Oncology - to discuss how #genetic #sequencing data is best implemented in patient management. Jan 29 at FDA or online https://t.co/8d9TfMaoU5 #NGS

2/3 #FDA approval of IV saline products from add’l companies further expected to increase product supply in US market in the next few weeks. Also looking to extend expiration dates for IV saline products, if data supports safe use, to allow some near-expi

#FDA has launched a new education campaign, targeting providers; to educate on, and promote, wider use of #biosimilars https://t.co/pvhSqCzUIw https://t.co/5LKo6rLRJj

3/3 Despite improving situation it may take time for new product supply to reach across market; indiv. institutions may have hard time obtaining adequate stock. Addressing this is a very high priority for FDA; we’re monitoring closely, taking swift action

“Injustice anywhere is a threat to justice everywhere. We are caught in an inescapable network of mutuality, tied in a single garment of destiny. Whatever affects one directly, affects all indirectly.” Martin Luther King Jr https://t.co/ANakx2giXF

RT @JohnsHopkinsSPH: Join #JHSPH and other institutions for a discussion on transparency at the @US_FDA with commissioner @SGottliebFDA.… https://t.co/FX0Siw3DOU

RT @SenAlexander: In 1963, I stood on the National Mall and listened to Dr. King call to "let freedom ring." His words inspire and ch… https://t.co/I2oCrafDyM

RT @drJoshS: Interested in #transparency at @US_FDA? Tomorrow is your day. Check out the webcast led by @SGottliebFDA starting… https://t.co/44BavgBZpl

RT @lauriemcginley2: FDA Commissioner @SGottlieb on new steps to increase transparency of new-drug clinical trial information. https://t.co/HE2d1J9g0m

RT @ikeswetlitz: At @statnews, every day is a day for #transparency at the @US_FDA. Tune in today at 9am to hear @SGottliebFDA discuss the… QT @drJoshS: Interested in #transparency at @US_FDA? Tomorrow is your day. Check out the webcast led by @SGottliebFDA starting… https://t.co/44BavgBZpl)

RT @CDCFlu: Flu activity is widespread in most of the U.S. It is not possible to say when #flu season will end, and significant… https://t.co/GR0hC8Pgj5

RT @ZacharyBrennan: Ahead of Gottlieb's speech at Johns Hopkins on transparency, FDA announces new pilot to release "nine recently-appr… https://t.co/0EFuE3bdd0

RT @US_FDA: FDA Commissioner @SGottliebFDA on new steps @US_FDA is taking to enhance transparency of clinical trial information… https://t.co/7QV0H2tk8Y

RT @drJoshS: Great timing— just after @SGottliebFDA announces pilot to make CSRs public, Professor Dickerson @JohnsHopkinsSPH ex… https://t.co/ykEZCpbkaq

RT @US_FDA: FDA Commissioner @SGottliebFDA today @JohnsHopkinsSPH discussing new ways the FDA is working to better foster trans… https://t.co/VkNxhFx6fl

RT @JohnsHopkinsSPH: Watch @US_FDA Commissioner @SGottliebFDA speak live: https://t.co/0rPWOvVrgn https://t.co/vNCvD88Pck QT @US_FDA: FDA Commissioner @SGottliebFDA today @JohnsHopkinsSPH discussing new ways the FDA is working to better foster trans… https://t.co/VkNxhFx6fl)

RT @dgingery: It's a breakthrough-like program for these products. https://t.co/zHDWSwrPer QT @SGottliebFDA: #FDA and DoD launch new program to expedite availability of medical products for the emergency care of American mil… https://t.co/bwdVW16v84)

RT @FDA_MCMi: Learn more about FDA’s work plan for products relevant to @DeptofDefense: https://t.co/ycXQhbaqpe https://t.co/HMpjpdLEr4 QT @FDAMedia: FDA and DoD launch program to expedite availability of medical products for the emergency care of American military… https://t.co/KrkAQwilN7)

RT @SueDHellmann: “Imagine what’s possible if we work together,” Gates said.” Many great examples of how we work with the private sector- i… QT @gatesfoundation: "@gavi and @GlobalFund show people that if you do come up with an innovation, there’s funding to get them out to de… https://t.co/hYZoSVeq1U)

1/3 #FDA expects shortage of IV fluids to improve in coming weeks. We're working with manufacturers to get #PuertoRico facilities to full capacity; also permitting imports of product to US from 3 new manufacturers; looking at add’l import sites for saline

#FDA Workshop: Weighing the Evidence - Variant Classification and Interpretation in Precision Oncology - to discuss how #genetic #sequencing data is best implemented in patient management. Jan 29 at FDA or online https://t.co/8d9TfMaoU5 #NGS

2/3 #FDA approval of IV saline products from add’l companies further expected to increase product supply in US market in the next few weeks. Also looking to extend expiration dates for IV saline products, if data supports safe use, to allow some near-expi

#FDA has launched a new education campaign, targeting providers; to educate on, and promote, wider use of #biosimilars https://t.co/pvhSqCzUIw https://t.co/5LKo6rLRJj

3/3 Despite improving situation it may take time for new product supply to reach across market; indiv. institutions may have hard time obtaining adequate stock. Addressing this is a very high priority for FDA; we’re monitoring closely, taking swift action

“Injustice anywhere is a threat to justice everywhere. We are caught in an inescapable network of mutuality, tied in a single garment of destiny. Whatever affects one directly, affects all indirectly.” Martin Luther King Jr https://t.co/ANakx2giXF

RT @JohnsHopkinsSPH: Join #JHSPH and other institutions for a discussion on transparency at the @US_FDA with commissioner @SGottliebFDA.… https://t.co/FX0Siw3DOU

RT @SenAlexander: In 1963, I stood on the National Mall and listened to Dr. King call to "let freedom ring." His words inspire and ch… https://t.co/I2oCrafDyM

RT @drJoshS: Interested in #transparency at @US_FDA? Tomorrow is your day. Check out the webcast led by @SGottliebFDA starting… https://t.co/44BavgBZpl

RT @lauriemcginley2: FDA Commissioner @SGottlieb on new steps to increase transparency of new-drug clinical trial information. https://t.co/HE2d1J9g0m

RT @ikeswetlitz: At @statnews, every day is a day for #transparency at the @US_FDA. Tune in today at 9am to hear @SGottliebFDA discuss the… QT @drJoshS: Interested in #transparency at @US_FDA? Tomorrow is your day. Check out the webcast led by @SGottliebFDA starting… https://t.co/44BavgBZpl)

RT @CDCFlu: Flu activity is widespread in most of the U.S. It is not possible to say when #flu season will end, and significant… https://t.co/GR0hC8Pgj5

RT @ZacharyBrennan: Ahead of Gottlieb's speech at Johns Hopkins on transparency, FDA announces new pilot to release "nine recently-appr… https://t.co/0EFuE3bdd0

RT @US_FDA: FDA Commissioner @SGottliebFDA on new steps @US_FDA is taking to enhance transparency of clinical trial information… https://t.co/7QV0H2tk8Y

RT @drJoshS: Great timing— just after @SGottliebFDA announces pilot to make CSRs public, Professor Dickerson @JohnsHopkinsSPH ex… https://t.co/ykEZCpbkaq

RT @US_FDA: FDA Commissioner @SGottliebFDA today @JohnsHopkinsSPH discussing new ways the FDA is working to better foster trans… https://t.co/VkNxhFx6fl

RT @JohnsHopkinsSPH: Watch @US_FDA Commissioner @SGottliebFDA speak live: https://t.co/0rPWOvVrgn https://t.co/vNCvD88Pck QT @US_FDA: FDA Commissioner @SGottliebFDA today @JohnsHopkinsSPH discussing new ways the FDA is working to better foster trans… https://t.co/VkNxhFx6fl)

RT @dgingery: It's a breakthrough-like program for these products. https://t.co/zHDWSwrPer QT @SGottliebFDA: #FDA and DoD launch new program to expedite availability of medical products for the emergency care of American mil… https://t.co/bwdVW16v84)

RT @FDA_MCMi: Learn more about FDA’s work plan for products relevant to @DeptofDefense: https://t.co/ycXQhbaqpe https://t.co/HMpjpdLEr4 QT @FDAMedia: FDA and DoD launch program to expedite availability of medical products for the emergency care of American military… https://t.co/KrkAQwilN7)